Risk management (7)
7.1 Practising in such a way as to minimise
the risk to patients of harm or error
7.2 Fully informing patients about their
diagnosis, treatment and prognosis
7.3 Explaining why a treatment is being
prescribed, or a management plan proposed, and the anticipated
benefits and potential side effects
7.4 Discussing the advantages and
disadvantages of alternative courses of action
7.5 Effectively communicating risk by
exchanging information, preferences, beliefs and opinions with
patients about those risks
7.6 Providing clear explanations of the
nature of clinical evidence and its interpretation
7.7 Ensuring appropriate follow up
arrangements and ‘safety-netting’
7.8 Improving patient safety by critical
event reporting, clinical audit, analysis of patients’ complaints
or information provided by colleagues
7.9 Responding to criticisms or complaints
promptly and constructively, and demonstrating an ability to learn
from them
7.10 Being aware of the obligations for
notifying outside agencies, for example, regarding safety of
medicines and devices to the Medicines Control Agency, and
notifiable diseases